These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 17447826)
1. Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights. Gentile S CNS Drugs; 2007; 21(5):367-87. PubMed ID: 17447826 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of atypical antipsychotics in bipolar disorder. Berk M; Dodd S Drugs; 2005; 65(2):257-69. PubMed ID: 15631544 [TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics: newer options for mania and maintenance therapy. Vieta E; Goikolea JM Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764 [TBL] [Abstract][Full Text] [Related]
11. A Review of the Pharmacological and Clinical Profile of Newer Atypical Antipsychotics as Treatments for Bipolar Disorder: Considerations for Use in Older Patients. Vasudev A; Chaudhari S; Sethi R; Fu R; Sandieson RM; Forester BP Drugs Aging; 2018 Oct; 35(10):887-895. PubMed ID: 30187288 [TBL] [Abstract][Full Text] [Related]
12. [Atypical antipsychotics in the treatment of bipolar affective disorders]. Hilger E; Barnas C Fortschr Neurol Psychiatr; 2002 May; 70(5):234-42. PubMed ID: 12007074 [TBL] [Abstract][Full Text] [Related]
13. The role of atypical antipsychotics in bipolar depression and anxiety disorders. McIntyre R; Katzman M Bipolar Disord; 2003; 5 Suppl 2():20-35. PubMed ID: 14700010 [TBL] [Abstract][Full Text] [Related]
14. Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder. Atkin T; Nuñez N; Gobbi G J Child Psychol Psychiatry; 2017 Aug; 58(8):865-879. PubMed ID: 28474733 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic agents in the treatment of bipolar mania. Tohen M; Vieta E Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685 [TBL] [Abstract][Full Text] [Related]
16. Spotlight on olanzapine in bipolar I disorder. McCormack PL; Wiseman LR CNS Drugs; 2005; 19(6):553-5. PubMed ID: 15963003 [TBL] [Abstract][Full Text] [Related]
17. Treating mixed mania/hypomania: a review and synthesis of the evidence. Takeshima M CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626 [TBL] [Abstract][Full Text] [Related]
18. Economics of atypical antipsychotics in bipolar disorder: a review of the literature. Fleurence RL; Dixon JM; Revicki DA CNS Drugs; 2006; 20(7):591-9. PubMed ID: 16800717 [TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications. Brugue E; Vieta E Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):275-82. PubMed ID: 16876306 [TBL] [Abstract][Full Text] [Related]